Metabolic Syndrome - International Academy of Homotoxicology

More documents

Recommendations

Info

) S p e c i a l i z e d A p p l i c a t i o n s Infusion protocols in metabolic syndrome ) 22 Infusion for metabolic syndrome/obesity • Graphites-Injeel (Ed. note: or Graphites-Homaccord) • Hepar compositum • Nux vomica-Injeel (Ed. note: or Nux vomica-Homaccord) • Lymphomyosot • Traumeel • Acidum DL-malicum-Injeel Infusion for metabolic syndrome with high blood pressure (adjuvant) • Melilotus-Homaccord • Rauwolfia compositum • Arteria suis-Injeel • Traumeel • Lymphomyosot Infusion for metabolic syndrome with pancreatic insufficiency • Pankreas suis-Injeel • Acidum DL-malicum-Injeel • Momordica compositum • Traumeel • Lymphomyosot Infusion for metabolic syndrome with mild to moderate circulatory disturbances • Circulo-Injeel • Placenta compositum • Vertigoheel • Traumeel • Lymphomyosot • Cerebrum compositum (in cerebral circulatory disturbances) Infusion for metabolic syndrome with polyneuropathy • Lymphomyosot • Vitamin B 6 • Vitamin B 12 • Traumeel • Vertigoheel • Selenium • Vitamin C (administered as a separate infusion) Infusion for metabolic syndrome with hyperhomocysteinemia • Vitamin B 6 • Vitamin B 12 • Folic acid • Traumeel • Vertigoheel • Circulo-Injeel • Cerebrum compositum (for cerebral circulatory disorders) If the catalysts of the citric acid (Krebs) cycle are available, patients will derive great benefit (in the form of improved metabolism) from yearly or twice-yearly infusions of these catalysts (see case study on page 12 and the article on citric acid cycle catalysts on page 16 of this journal). Ideally, the catalyst infusions should be administered every two weeks and in alternation with any of the infusions listed above, to a total of three citric acid cycle infusions, after which the basic infusions can be continued without the interspersed catalyst infusions. The patients’ subjective wellbeing is greatly enhanced by these treatments, and objective signs such as blood pressure, blood sugar levels, and cholesterol levels also improve. For all of these reasons, patients usually return without being reminded for their next annual infusion series and recommend the infusions to relatives and friends.| Journal of Biomedical Therapy 2008 ) Vol. 2, No. 1
) Practical Protocols Detoxification and Drainage in Metabolic Syndrome By Bruce H. Shelton, MD, MD(h), DiHom Detoxification is an important component in the basic treatment of metabolic syndrome patients. Individuals with central obesity are a high risk group, not only because of the inflammatory potential of fatty tissue but also because fatty tissue is a reservoir for toxins (see BT 2/2007, page 13). For this reason, these patients need fairly gradual detoxification with adequate support of the organs of detoxification and drainage. (Esthetic mesotherapy in particular mobilizes fat tissue, releasing stored toxins, so these patients always need advanced organ support, followed by a long period of drainage with the Detox- Kit.) We seek a delicate balance in treating patients with metabolic syndrome: Weight loss is imperative because inflammatory fatty tissue poses a risk to the entire organism, but mobilizing fat releases dangerous toxins, which may exacerbate the pathology. For these patients, Thyreoidea compositum is a good choice because of its metabolic, immunologic, and organ-strengthening properties. Fatty tissue (simply another form of connective tissue) is supported by the Funiculus umbilicalis suis in the product. In patients who develop central obesity as a consequence of stress or extraneous cortisone use, Pulsatilla compositum is especially useful and can replace the Thyreoidea compositum. The catalysts are mandatory in these conditions. Many of these patients develop gallstones during rapid breakdown of fatty tissue. Patients at high risk (especially fair-skinned females over 40 years of age) can be supported by adding Chelidonium-Homaccord to the Detox-Kit during the drainage phase. (See protocol in Table 1.)| Disease-specific treatment Strumeel and/or Syzygium compositum, Cralonin, Barijodeel Followed by detoxification treatment: Always do advanced organ support first Weeks 1-6 or until point count is < 100 Liver Urinary tract/ Kidney Lymph Skin Gut Gallbladder Connective tissue Respiratory tract Advanced organ support Hepar comp. Solidago comp. Hepar comp. Thyreoidea comp. Alternative products Hepeel Reneel Galium-Heel/ Lymphomyosot Nux vomica- Homaccord Leber-Galle Tropfen Pulsatilla comp. For cellular detoxification, add: Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Note Dosage The metabolically active medications Hepar compositum and Coenzyme compositum can also be injected into ST 36 (0.5 cc of the mixture into the AP point). Ampoules: In general, 3-1 times weekly 1 ampoule i.m., s.c., i.d. Drops: In general, 10 drops 3 times daily After six weeks or when point count < 100: Basic detoxification and drainage Liver Urinary tract/ Kidney Lymph Skin Gut Gallbladder Connective tissue Basic detoxification and drainage Detox-Kit Detox-Kit Detox-Kit Detox-Kit Chelidonium- Homaccord Detox-Kit For cellular detoxification, add: Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Coenzyme comp./ Ubichinon comp. (or Ubicoenzyme) Note Dosage In very obese patients, continue with Thyreoidea compositum/Pulsatilla compositum for 12 weeks longer. Ampoules: In general, 3-1 times weekly 1 ampoule i.m., s.c., i.d. Drops: In general, 10 drops 3 times daily ) 23 Table 1: Detox protocol for metabolic syndrome Journal of Biomedical Therapy 2008 ) Vol. 2, No. 1
Page 1 and 2: d 2.00 • US $ 2.00 • CAN $ 3.00
Page 3 and 4: ) A Challenge for the Future: Fight
Page 5 and 6: ) In Focus Table 2: Effects of adip
Page 7 and 8: ) In Focus Elevated blood pressure
Page 9 and 10: ) What Else Is New? Educational aid
Page 11 and 12: ) From the Practice factors, in thi
Page 13 and 14: ) From the Practice Photo by Ann Mu
Page 15 and 16: ) A r o u n d t h e G l o b e ACAM
Page 17 and 18: ) Refresh Your Homotoxicology Natri
Page 19 and 20: ) Marketing Your Practice When a pa
Page 21: ) S p e c i a l i z e d A p p l i c
Page 25 and 26: ) Making of ... Left: The fodder of
Page 27 and 28: ) Crossword Puzzle Re s e a r c h H

Metabolic Syndrome - International Academy of Homotoxicology

Create successful ePaper yourself

Delete template?

Save as template?